| |
| FDA Official and Title | Date and Site | Other FDA Participants | Non-FDA Participants | Subject |
---|---|---|---|---|---|
Michael A. Friedman, M.D. Lead Deputy Commissioner | 5/7 Capitol Hill | Diane Thompson, Assoc. Cmsr. For Leg. Afrs. And others | Representative Shaws; & others | Congressional Hearing on IGIV (testimony is available) | |
Sharon Smith Holston Deputy Commissioner for External Affairs | 5/4 Parklawn | Walter Batts/OIA, Linda Horton/OP | Chris Sizemore and Gary Yingling National Pharmaceutical Alliance | TABD Process | |
Sharon Smith Holston Deputy Commissioner for External Affairs | 5/7 Parklawn | Terry Toigo/OSHI, Carrie Smith Hanley/OEA Operations, Dana Delman/ExSec | Patient Coalition Representatives | OSHI/OCA Re-design | |
David Feigal, M.D. Deputy for Medicine, CBER | 5/5 Bethesda, MD | none | Members of American Red Cross (ARC) | Courtesy visit | |
Kathryn Zoon, Ph.D. Director, CBER | 5/6 Bethesda, MD | none | Gillian Woollet Bert Spilker PhRMA | Courtesy Visit | |
Dr. Stuart L. Nightingale Associate Commissioner for Health Affairs | 4/27 Washington, DC | Michelle Limoli | John Erhardt and others from Global Business Forum | Pharmaceutical issues at the World Health Assembly | |
Dr. Stuart L. Nightingale Associate Commissioner for Health Affairs | 4/29 Bethesda, MD | Roger Williams Michelle Limoli Jaime Henriquez | Harvey Bale, IFPMA; Enrique Fefer, Rosario D'Alessio, PAHO | Drug Harmonization in the Americas | |
Dr. Stuart L. Nightingale Associate Commissioner for Health Affairs | 4/30 Atlanta, GA | none | Members of the Bd. Of Scientific Coun., Natl Ctr. For Infectious Diseases | NCID Program |
May 11, 1998